Skip to main content
Clinical Trials/JPRN-UMIN000000681
JPRN-UMIN000000681
Unknown
未知

A Randomized Comparative Clinical Study on Suppression of Progression from Early Diabetes, Diet/exercise Standard Intervention vs. Concurrent Pharmacological Standard Intervention - Japan Early Diabetes Intervention Study (JEDIS)

Japan Early Diabetes Intervention Study (JEDIS) Group0 sites2,560 target enrollmentApril 18, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
ewly-diagnosed early diabetes
Sponsor
Japan Early Diabetes Intervention Study (JEDIS) Group
Enrollment
2560
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2007
End Date
December 1, 2010
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan Early Diabetes Intervention Study (JEDIS) Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a. Type 1 diabetes mellitus b. Undergoing treatment with steroids c. Secondary diabetes mellitus d. Diabetes mellitus due to suspected mitochondrial gene abnormalities or other gene abnormalities e. Very obese (BMI \>\= 35 kg/m2\) or underweight (BMI \< 18\.5 kg/m2\) f. Undergone a gastrectomy or abdominal surgery g. Severe hyperuricemia (gout) associated with organ dysfunction caused by hyperuricemia h. Severe vascular diseases with organ dysfunction i. Cancer or other malignant neoplasms j. Liver cirrhosis or chronic hepatic, chronic renal failure k. Gastrointestinal disorders such as diarrhea and vomiting l. Always performing rigorous muscular exercise m. Severe infection or serious trauma or, who are scheduled to undergo or who have just undergone surgery n. Women who are pregnant or with a possibility of pregnancy o. Alcohol dependence or drug dependence p. Drug allergy q. Anemic (males: Hb \< 13 g/dL; females: Hb \< 11 /dL) r. Abnormal hemoglobinuria. s. Severe mental disease undergoing treatment, Other individuals whom the investigator deems unsuitable for inclusion in this study (e.g., individuals who are very likely to be transferred to another locality during the course of the study)

Outcomes

Primary Outcomes

Not specified

Similar Trials